TAYLOR MURPHY: Open Payments
NPI 1023530136 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 14 payments from 7 companies in 2025. Trend: 2023 $176 · 2024 $118 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 3 | $117 |
| Janssen Biotech, Inc. | 4 | $82 |
| Boston Scientific Corporation | 2 | $46 |
| Kerecis Limited | 2 | $27 |
| Astellas Pharma US Inc | 1 | $20 |
| TOLMAR, INC. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
Products named: ERLEADA, JELMYTO, XTANDI, AMS 800 Artificial Urinary Sphincter, Kerecis SurgiClose, JATENZO, AMS 700.
Industry payments across LA — which companies pay providers there.
